Residency · Riverside, CA
Sponsored by Riverside University Health System
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study.
Ophthalmology · 2022 · 140 citations · Amy Patel
Update on the Selection Criteria of Plastic Surgery Residents: A Survey of Program Directors and Associate Program Directors.
Annals of plastic surgery · 2024 · 19 citations · Arya Asghari
Teprotumumab reduces extraocular muscle and orbital fat volume in thyroid eye disease.
The British journal of ophthalmology · 2022 · 56 citations · Amy Patel
Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease.
The Journal of clinical endocrinology and metabolism · 2023 · 55 citations · Amy Patel
Naltrexone for alcohol use disorder: Hepatic safety in patients with and without liver disease.
Hepatology communications · 2022 · 55 citations · Jennie Yoo
Medical student's perception of the COVID-19 pandemic effect on their education and well-being: a cross-sectional survey in the United States.
BMC medical education · 2022 · 34 citations · Anthony Diomino
Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial.
The American journal of psychiatry · 2021 · 64 citations · Stefan Ursu
Effectiveness and Minimum Effective Dose of App-Based Mobile Health Interventions for Anxiety and Depression Symptom Reduction: Systematic Review and Meta-Analysis.
JMIR mental health · 2022 · 29 citations · Mindy Xu